Traduction de «months of » (Néerlandais → Français) :

- At the end of the follow-up and potential referral, the suicidal individuals are contacted again by telephone (provided they have agreed to this) after a period of one month / three months / six months / a year, in order to maintain contact and assess their general evolution.
- au terme du suivi et de l’orientation éventuelle, un contact téléphonique est repris avec le suicidant (pour autant qu’il ait manifesté son accord) à l’échéance d’un mois / trois mois / six mois / un an afin de maintenir le lien et jauger l’évolution générale de la personne.

Treatment (both NRT and bupropion) lasts at least 1 month Retail price of NRT gum: not reported Retail price of NRT patch (3-month course): €354.54 (€, 2001) Retail price of NRT nasal spray (3-months course): €743.02 3% (range 0-5% in sensitivity analysis)
Treatment (both NRT and Buproprion) lasts at least 1 month Retail price of NRT gum: not reported Retail price of NRT patch (3-month course): €354.54 (€, 2001) Retail price of NRT nasal spray (3-months course): €743.02 3% (range 0-5% in sensitivity analysis)

Bestand STAYHOSP Velden: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT, A2_HOUR_HOSP_OUT, A2_MIN_HOSP_OUT en PATNUM
Fichier STAYHOSP Champs : CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2 _ DAY _ HOSP _IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT, A2_HOUR_HOSP_OUT, A2_MIN_HOSP_OUT et PATNUM

Bestand STAYHOSP Velden: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT, A2_CODE_INDIC_AGE en A2_CODE_SEX
Fichier STAYHOSP Champs: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT, A2_CODE_INDIC_AGE en A2_CODE_SEX

Bestand CAMPUNIT Velden: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, CODE_CAMPUS, CODE_UNIT, S3_YEAR_START_UNIT, S3_MONTH_START_UNIT, S3_DAY_START_UNIT, S3_YEAR_END_UNIT, S3_MONTH_END_UNIT en S3_DAY_END_UNIT
Fichier CAMPUNIT Champs : CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, CODE_CAMPUS, CODE_UNIT, S3_YEAR_START_UNIT, S3_MONTH_START_UNIT, S3_DAY_START_UNIT, S3_YEAR_END_UNIT, S3_MONTH_END_UNIT et S3_DAY_END_UNIT

Bestand STAYHOSP Velden: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT, A2_CODE_INDIC_AGE en PATNUM
Fichier STAYHOSP Champs: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT, A2_CODE_INDIC_AGE en PATNUM

Bestand STAYHOSP Velden: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT en A2_CODE_INDIC_AGE
Fichier STAYHOSP Champs: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT, A2_DAY_HOSP_OUT et A2_CODE_INDIC_AGE

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

Odds ratio of NRT versus control: 1.67 Odds ratio of bupropion versus control: 2.1 Odds ratio of NRT+bupropion versus control: 2.65 From these Odds Ratios and information on the control 12-month quit rate in the comparator intervention (0.04 for brief advice and 0.10 for counselling), the 12-month quit rate of treatment is calculated: treated quit rate for brief advice+NRT: 0.0650 treated quit rate for brief advice+bupropion: 0.0805 treated quit rate for brief advice+bupropion+NRT: 0.0994 treated quit rate for counselling+NRT: 0.1565 treated quit rate for counselling+bupropion: 0.1892 treated quit rate for counselling+bupropion+NRT: 0.2275 spontaneous cessation rate: 0.01. lifetime relapse rate: 40% (range 30-50%). number of LYG per quitter: 2 (range 1-3). number of QALYs gained per quitter: 2.7 (range 1.35-4.05) not reported The table gives an overview of the assumptions with respect to costs and effects (quit rates) in the average scenario.
Odds ratio of NRT versus control: 1.67 Odds ratio of Buproprion versus control: 2.1 Odds ratio of NRT+Buproprion versus control: 2.65 From these Odds Ratios and information on the control 12-month quit rate in the comparator intervention (0.04 for brief advice and 0.10 for counselling), the 12-month quit rate of treatment is calculated: treated quit rate for brief advice+NRT: 0.0650 treated quit rate for brief advice+Buproprion: 0.0805 treated quit rate for brief advice+Buproprion+NRT: 0.0994 treated quit rate for counselling+NRT: 0.1565 treated quit rate for counselling+Buproprion: 0.1892 treated quit rate for counselling+Buproprion+NRT: 0.2275 spontaneous cessation rate: 0.01. lifetime relapse rate: 40% (range 30-50%). number of LYG per quitter: 2 (range 1-3). number of QALYs gained per quitter: 2.7 (range 1.35-4.05) not reported The table gives an overview of the assumptions with respect to costs and effects (quit rates) in the average scenario.

Bestand STAYHOSP Velden: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT en A2_DAY_HOSP_OUT
Fichier STAYHOSP Champs: CODE_AGR, YEAR_REGISTR, PERIOD_REGISTR, STAYNUM, A2_YEAR_HOSP_IN, A2_MONTH_HOSP_IN, A2_DAY_HOSP_IN, A2_YEAR_HOSP_OUT, A2_MONTH_HOSP_OUT et A2_DAY_HOSP_OUT